EVs produced by lung cancer cells are reported to stimulate the production of the pro-angiogenic factor vascular endothelial growth factor (VEGF) and increase vascular permeability and extracellular matrix remodeling [312]. This evidence concerns the gene VEGFA and lung cancer.